10-Q
MEDICINES CO /DE filed this form 10-Q on 15 May 2002
- velhartice.info
<PAGE>


                      PROTOCOL SYNOPSIS - CLEVIDIPINE CABG



<TABLE>
<S>                                         <C>
NAME OF SPONSOR:                            AstraZeneca and The Medicines Company

NAME OF ACTIVE INGREDIENT:                  Clevidipine

TITLE OF STUDY:                             [**]

STUDY CENTERS:                              [**]

PHASE OF DEVELOPMENT:                       [**]

OBJECTIVES:                                 [**]

METHODOLOGY:                                [**]

NUMBER OF PATIENTS:                         [**]

DIAGNOSIS AND MAIN CRITERIA FOR INCLUSION:  [**]

TEST PRODUCT(S), DOSE, MODE OF
ADMINISTRATION:                             [**]

REFERENCE THERAPY, DOSE, MODE OF
ADMINISTRATION:                             [**]

DURATION OF TREATMENT:                      [**]

CRITERIA FOR EVALUATION:

Efficacy:                                   [**]

                                            [**]

                                            [**]

                                            [**]

                                            [**]

                                            [**]

                                            [**]

Safety:                                     [**]

SAMPLE SIZE:                                [**]
</TABLE>